Complete guides, comparisons and scientific analyses on peptides in skincare, health and biohacking.
A chronological, evidence-based look at how semaglutide's effects on weight, appetite, glycemic control and cardiovascular risk emerge over time.
From two-minute native hormones to once-weekly analogs — the pharmacology of peptide clearance, the modifications that extend it (DAC, PEGylation, lipidation), and what the data actually shows.
A balanced look at reported reactions, hormonal and metabolic considerations, and the regulatory status of this GHRH analog.
A scientific panorama of signal, carrier, neurotransmitter-inhibiting and enzyme-inhibiting peptides used in modern skincare.
How a triple incretin agonist compares with the first approved dual GIP/GLP-1 receptor agonist — receptors, evidence, and open questions.
A balanced, evidence-based review of the reported and theoretical safety profile of TB-500 (Thymosin Beta-4) as a research peptide.
How to identify high-quality hydrolyzed collagen, which certifications actually matter, and how to spot the products that waste your money.
Matrixyl, Argireline, and copper peptides compared — what the research actually shows, and how to pick the right serum for your skin.
A rigorous, evidence-based look at how BPC-157 is proposed to work in animal models — angiogenesis, cell signaling pathways, and the limits of the current data.
A clinical pharmacology guide to the incretin-based molecules reshaping diabetes and obesity care — and where each one differs.
Two of the most talked-about skincare ingredients do fundamentally different jobs. Here is what the science actually says about how they work, where they overlap, and how to combine them.
A pharmacology-focused look at how acetyl hexapeptide-8 interferes with SNARE-mediated neurotransmitter release — and what the cosmetic clinical evidence really tells us.